Results 291 to 300 of about 216,999 (320)

Identifying Common Disease Trajectories of Progressive Supranuclear Palsy with Electronic Health Records

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 10, Page 1528-1538, October 2025.
Abstract Background Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder characterized by parkinsonism and impairments in balance, language, and cognition. As an atypical parkinsonism, PSP progresses rapidly, lacks effective treatments, and poses significant caregiving burdens. While prior studies have identified risk factors, they
Mingzhou Fu   +3 more
wiley   +1 more source

Health‐Related Quality of Life in Relation to the 5‐2‐1 Criteria in Parkinson's Disease in Sweden

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 10, Page 1511-1519, October 2025.
Abstract Background Device‐aided therapies (DAT) offer alternatives to oral or transdermal dopaminergic treatments in advanced Parkinson's disease (PD), where they can reduce motor fluctuations and dyskinesia and improve health‐related quality of life (HRQoL).
Frida Hjalte   +5 more
wiley   +1 more source

Longitudinal Assessment Reveals Stage‐Dependent Utility of Digital Motor Markers in SCA1

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 10, Page 1622-1628, October 2025.
Abstract Background Clinical trials in spinocerebellar ataxias (SCA) require objective, quantifiable outcome measures sensitive to changes in disease severity. Objectives The objective was to study the sensitivity to change of digital gait biomarkers in SCA1 over a 1‐year period. Methods Seventeen SCA1 patients and 15 controls walked 30 seconds wearing
Ilse H.J. Willemse   +3 more
wiley   +1 more source

An Educational Program for Remote Training and Supervision of Home-Based Transcranial Electrical Stimulation: Feasibility and Preliminary Effectiveness. [PDF]

open access: yesNeuromodulation
Cappon D   +8 more
europepmc   +1 more source

The Unseen Burden: Uncovering Shame and Its Determinants in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 10, Page 1551-1559, October 2025.
Abstract Background Shame is frequent in Parkinson's disease (PD) and often overlooked. Objective The aim was to assess factors associated with PD‐related shame. Methods PD‐related shame was measured using the Shame and Embarrassment in PD (SPARK) scale in patients without cognitive impairment.
Sabina Catalano Chiuvé   +6 more
wiley   +1 more source

Association between Perceived Dysphagia Symptoms and Swallowing Physiology in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, Volume 12, Issue 10, Page 1571-1581, October 2025.
Abstract Background Swallowing disorders are prevalent in Parkinson's disease (PD). Swallowing assessment often relies on patient‐reported outcome measures (PROMs). Although PROMs and physiologic swallowing measures correlate with disease severity, the relationship between PROMs and physiologic swallowing impairments is unclear.
Rabab Rangwala   +4 more
wiley   +1 more source

Compressive Cervical Myelopathy Causing Impaired Gait after Deep Brain Stimulation Is Not Rare

open access: yes
Movement Disorders Clinical Practice, Volume 12, Issue 10, Page 1672-1674, October 2025.
Caroline Weill   +6 more
wiley   +1 more source

Non-invasive transcranial electrical brain stimulation guided by functional near-infrared spectroscopy for targeted neuromodulation: a review

Journal of Neural Engineering, 2022
One of the primary goals in cognitive neuroscience is to understand the neural mechanisms on which cognition is based. Researchers are trying to find how cognitive mechanisms are related to oscillations generated due to brain activity.
K. Hong, M. N. A. Khan, Usman Ghafoor
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy